CHYM: Crosslink affiliates propose selling 36,000 Chime shares

Crosslink affiliates, linked to a Chime Financial director, plan to sell 36,000 shares (~$1.2M) on NASDAQ around 11/13/2026. This follows recent sales of 1.2M shares by Crosslink-related entities. The proposed sale is small relative to the 353M shares outstanding.

Original reporting
Published Nov 13, 2026, 9:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 14, 2026, 4:21 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CHYM
Bearish
medium confidence
Mentioned
$CHYM
Relevance
4/10
AlphAI data visualization · based on quantisnow.com
Decision brief

The 30-second read

$CHYMBearishLow
01

Why it matters

The filing provides the first public notice of the upcoming sale, offering traders a brief window to anticipate any price reaction.

02

Market read

A modest insider sale that may cause short‑term pressure but is unlikely to move the broader market.

03

What to watch

Potential future sales from the same affiliate group or other insiders could increase cumulative supply.

Relevance 4/10Novelty 4/10Timing: sale scheduled for 11/13/2026

Background

Form 144 filing indicates a pre‑planned sale by a director‑linked affiliate, a routine disclosure for insiders with control stock.

Company-level read

Ticker impact

$CHYMBearishMedium confidence
Context

Crosslink affiliates propose selling 36,000 CHYM shares (~$1.2M) on 11/13/2026, representing a small portion of the 353M shares outstanding.

Expected impact

likely modest downward pressure as the market prices in the additional supply.

Evidence & confidence

The sale size is small relative to float, but insider affiliation may prompt short‑term selling interest.

Market effects

Minimal impact on the broader fintech/consumer finance sector.

Limited to U.S. markets where CHYM trades.

Low; the filing does not affect global market dynamics.

Counterpoint

The sale could be interpreted as a signal of confidence if the insider believes the price is overvalued and wants to lock in gains.

Key entities

  • Chime Financial, Inc.

    U.S. fintech firm listed on NASDAQ under ticker CHYM.

  • Crosslink Crossover Fund VII, LP

    Director‑linked fund proposing the share sale.

Related articles

$CHYMHigh

Why is Chime Financial stock climbing today?

Chime Financial (CHYM) stock rose 2.8% in pre-market trading ahead of its inclusion in the S&P MidCap 400 index. Analysts raised price targets, with an average recommendation of 'Buy'. Q3 revenue grew 32% to $718M, and guidance was increased. The stock's gain contrasts with broader market declines.

$CHYMMed

Wells Fargo raises Chime Financial price target on strong results

Wells Fargo raised its price target for Chime Financial (CHYM) to $42.00 from $39.00, citing strong Q3 results and improved 2026 guidance. The company's revenue grew 26% with an 89% gross profit margin, though it remains unprofitable with an EPS of -$0.05. Chime's stock has gained 56% over the past year, trading at $29.87 with a market cap of $11.31 billion. The firm expects the Stride acquisition to close in early 2027, generating $100 million in annual synergies.

$CHYMHighAI 8/10

B.Riley raises Chime Financial stock price target on strong results

B.Riley raised its price target on Chime Financial (NASDAQ:CHYM) to $45.00, citing strong Q3 2026 results. Revenue was $718M, adjusted EBITDA $137M, both exceeding estimates. The company reported GAAP profitability for the third straight quarter, with net income of $44M. Active members reached 10.9M, and management raised full-year guidance. CHYM stock is up 56% over the past year, trading at $29.87.